Company Filing History:
1 out of 119 
1 out of 48 
Years Active: 2012
Title: Silke Bärreiter: Innovator in Tumor Treatment
Introduction
Silke Bärreiter is a prominent inventor based in Schriesheim, Germany. She has made significant contributions to the field of cancer research, particularly in the development of innovative treatments for tumors. Her work has garnered attention for its potential impact on therapeutic strategies.
Latest Patents
Silke Bärreiter holds a patent for the "Treatment of tumors using specific anti-L1 antibody." This invention relates to the anti-L1 monoclonal antibody 9.3, along with related antibodies or binding molecules. The patent emphasizes the uses of these antibodies, especially in tumor treatment, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Silke has worked with notable organizations, including the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Medigene AG. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Silke has collaborated with esteemed colleagues such as Daniela Kelm and Peter Altevogt. These partnerships have enriched her research and expanded the scope of her innovations in cancer treatment.
Conclusion
Silke Bärreiter's work exemplifies the vital role of inventors in the advancement of medical treatments. Her dedication to developing effective therapies for tumors highlights the importance of innovation in healthcare.